Upper Limit of Normal (ULN) in Medical Testing
The upper limit of normal (ULN) is defined as the 99th percentile value from a normal reference population without the disease or condition being measured, with the assay coefficient of variation ideally being 10% or less. 1, 2
Core Definition and Statistical Basis
ULN represents the threshold above which a test result is considered abnormal, typically set at the 95th or 99th percentile of values obtained from a healthy reference population 1, 2
For cardiac troponins specifically, the ULN is defined as the 99th percentile from a normal reference population without myocardial necrosis, with the coefficient of variation of the assay required to be 10% or less 1, 2
The cutoff value for elevated biomarkers may be set slightly above the upper limit of the performance characteristics of the assay for a normal healthy population 1
Clinical Application and Interpretation
ULN serves as the reference point for categorizing disease severity, with elevations described as multiples of the ULN (e.g., 2× ULN, 3× ULN, 5× ULN) 3, 4
In myocardial infarction, biomarkers like CK-MB rise to a peak of 2 to 5 times the ULN, while cardiac troponins show small elevations above the ULN in small infarctions but can rise to 20 to 50 times the ULN in large infarctions 1, 2
For liver enzymes, abnormal values are defined as any value above the ULN, with approximately 15-17% of COVID-19 patients showing elevations above this threshold 5
Important Considerations for ULN Determination
The ULN varies significantly by demographic factors including sex, age, and geographic location, requiring localized reference ranges rather than universal cutoffs 3, 6, 7, 8
For ALT specifically, optimal thresholds are suggested to be 30 U/L for men and 19 U/L for women, substantially lower than traditionally accepted values of 40-52 U/L 4, 6, 7, 9
Laboratory variation is significant, and results should be interpreted in the context of the specific laboratory's reference range and methodology 4
Practical Use in Clinical Decision-Making
Clinically relevant cutoffs should align with established reference values (e.g., ULN, 2×ULN, 3×ULN) rather than statistically derived values that may overfit specific patient cohorts 3
In pulmonary function testing, both the lower limit of normal (LLN) and upper limit of normal (ULN) are displayed on reports to show where results fall within the normal range 10
The ULN provides a standardized reference point for monitoring disease progression, treatment response, and identifying patients requiring further evaluation or intervention 4, 11
Common Pitfalls
Historical ULN values established in the 1980s likely included individuals with undiagnosed hepatitis C and nonalcoholic fatty liver disease, resulting in artificially elevated reference ranges that miss patients with early liver disease 12
Different assays may have different analytical sensitivities, making it essential for physicians to know the specific characteristics of tests used in their institutions 1, 2
The multiplicity of existing assays for some biomarkers (like cardiac troponin I) creates heterogeneity in ULN values across laboratories 1, 2